Target intelligence / Profile preview

T2 relaxation time (T2)

Target
T2
Molecular classification
Other
01

Overview

T2 relaxation time is a fundamental physical parameter in magnetic resonance imaging (MRI) that describes the rate at which the transverse component of the magnetization vector decays due to spin-spin interactions (StatPearls: MRI Physics, 2023 [1]). It is not a biological molecule, receptor, or enzyme, but rather a measurable property of tissue protons that reflects the local chemical and magnetic environment (Radiopaedia, 2023 [2]). In clinical practice, T2 relaxation time is used as a sensitive surrogate marker for various pathological states, as values typically increase in the presence of edema or inflammation and decrease in the presence of iron, hemorrhage, or certain minerals (NIH: National Institute of Biomedical Imaging and Bioengineering, 2022 [3]). While not a therapeutic target, it is the primary focus of diagnostic pharmacology involving T2 contrast agents, such as superparamagnetic iron oxide nanoparticles (SPIONs). These agents interact with the local magnetic field to significantly shorten the T2 relaxation time of surrounding water protons, thereby enhancing the contrast and visibility of specific tissues or lesions during imaging (PubChem: Ferumoxytol, 2023 [4]).

Other names
Transverse relaxation timeSpin-spin relaxation timeT2 decay timeT2 constant
02

Mechanism of action

Shortening of transverse relaxation time via local magnetic field inhomogeneities induced by paramagnetic or superparamagnetic substances

03

Biological functions

Tissue characterizationProton spin dynamicsFluid-tissue differentiationMagnetic resonance signal decay
04

Disease associations

EdemaInflammationMultiple sclerosis (T2 lesions)Cerebral ischemiaMyocardial infarctionIron overload (hemosiderosis)Tumor detection
05

Safety considerations

Nephrogenic systemic fibrosis (for gadolinium agents)Hypersensitivity reactionsIron toxicity (for iron-based agents)Artifact generation in MRI
06

Interacting drugs

Ferumoxytol

4 more in the full profile.

07

Biomarkers

T2 mappingQuantitative T2 valueT2-weighted signal intensityT2* (T2-star) relaxation

Beyond the preview

Go deeper on T2 relaxation time (T2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T2 relaxation time (T2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call